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http:WHAT THIS STUDY ADDS
Previous comparisons between open and endovascular repair of popliteal aneurysms have focused on
asymptomatic patients, and have short follow up. This study is strengthened by the fact that it is contemporary,
population based, without any selection bias, reporting on all kinds of presentations, and has approximately 90%
1 year follow up data. It shows that endovascular repair has signiﬁcantly inferior results compared with open
repair, in particular in the group of patients who present with acute ischaemia. We believe these results will
make many vascular surgeons think twice before they treat patients endovascularly in the future.Background: Popliteal aneurysm (PA) is traditionally treated by open repair (OR). Endovascular repair (ER) has
become more common. The aim was to describe time trends and compare results (OR/ER).
Methods: The Swedish vascular registry, Swedvasc, has a speciﬁc PA module. Data were collected (2008e2012)
and supplemented with a speciﬁc protocol (response rate 99.1%). Data were compared with previously published
data (1994e2002) from the same database.
Results: The number of operations for PA was 15.7/million person-years (8.3 during 1994e2001). Of 592
interventions for PA (499 patients), 174 (29.4%) were treated for acute ischaemia, 13 (2.2%) for rupture, 105
(17.7%) for other symptoms, and 300 (50.7%) were asymptomatic (31.5% were treated for acute ischaemia,
1994e2002, p ¼ .58). There were no differences in background characteristics between OR and ER in the acute
ischaemia group. The symptomatic and asymptomatic groups treated with ER were older (p ¼ .006, p < .001). ER
increased 3.6 fold (4.7% 1994e2002, 16.7% 2008e2012, p¼ .0001). Of those treated for acute ischaemia, a stent
graft was used in 27 (16.4%). Secondary patency after ER was 70.4% at 30 days and 47.6% at 1 year, versus 93.1%
and 86.8% after OR (p ¼ .001, <.001). The amputation rate at 30 days was 14.8% after ER, 3.7% after OR
(p ¼ .022), and 17.4% and 6.8% at 1 year (p ¼ .098). A stent graft was used in 18.3% for asymptomatic PA.
Secondary patency after ER was 94.5% at 30 days and 83.7% at 1 year, compared with 98.8% and 93.5% after OR
(p ¼ .043 and 0.026). OR was performed with vein graft in 87.6% (395/451), with better primary and secondary
patency at 1 year than prosthetic grafts (p ¼ .002 and <.001), and with a posterior approach in 20.8% (121/581).
Conclusions: The number of operations for PA doubled while the indications remained similar. ER patency was
inferior to OR, especially after treatment for acute ischaemia, and the amputation risk tended to be higher,
despite similar pre-operative characteristics.
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/).
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Popliteal artery aneurysm (PA) is a relatively uncommon
disease that has been difﬁcult to study.
Three previous studies of a large number of patients with
PA have been published. Ravn et al.1 reported 571 patients
with 717 legs treated in Sweden in 1987e2002: pre-
operative thrombolysis improved run-off and reduced the
risk of amputation when the patient presented with acute
ischaemia,2 and open repair (OR) with a posterior approach
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sults because of the reduced risk of late expansion.3 It was
not meaningful to compare OR and endovascular repair (ER)
during this time period. Johnson et al.4 studied the outcome
of open surgical treatment for popliteal aneurysm in 583
cases in 1994e2005. Low operative mortality and good limb
salvage rates were reported.
In a retrospective study from seven Italian centres, Pulli
et al.5 described the outcome of 312 treated PAs, of which
134 had received ER. There were discrepancies between the
two groups: more symptomatic patients (64% vs. 34%) and
acute presentations (23% vs. 6.5%) in the OR group, and
worse run-off score than patients treated with ER. Primary
and secondary patency rates were similar for OR and ER,
but the great differences in case mix were not addressed
when the results were analysed. At 24 months the ﬁgures
were similar, but in both groups more than half of the pa-
tients were lost to follow up, limiting the possibility to
evaluate the midterm outcome.
In many centres, OR remains the gold standard for
treatment of PA, even though there is diversity in the
preferred technique: posterior or medial approach, vein or
prosthetic graft. As endovascular treatment in general has
become more common, it has emerged as an alternative
treatment for PA. A minimally invasive procedure, per-
formed under local anaesthetic, with a short hospital stay is
an attractive option, but questions remain about its dura-
bility. A limited number of studies have been published,
with small cohorts of mostly asymptomatic patients, and
short follow up. In the Vascunet collaboration, PA repair
could be identiﬁed in eight countries for comparison of
contemporary treatment.6 The operations per million per-
son years varied from 3.4 in Hungary to 17.6 in Sweden.
Overall, surgery was elective in 72% of cases, but in Hungary
only 26%. The proportion of endovascular repair varied
from 35% in Australia to zero in Switzerland, Finland, and
Iceland.
The Swedvasc Registry7 introduced a speciﬁc registration
for treatment of PA in 2008, offering a unique possibility to
investigate these issues in a modern context. The overall
aim was to study contemporary treatment of PA, and how
the choice of technique affects 1 month and 1 year
outcomes.PATIENTS AND METHODS
The Swedish vascular registry, the Swedvasc, was created in
January 1987, and since 1992 has registered more than 90%
of open and endovascular vascular surgical procedures in
the country.7 In May 2008 the registry was thoroughly
revised. Instead of one set of variables for all vascular sur-
gical procedures, which had been used since the start,
speciﬁc modules were created for different standard oper-
ations, based on the indication for surgery. One such set of
modules was created for infra-inguinal arterial procedures,
with PA as one speciﬁc indication.
All procedures for PA, open or endovascular, conﬁned to
the popliteal fossa or extending into the superﬁcial femoralartery are registered in this speciﬁc module. Background
characteristics and details of surgical technique are regis-
tered prospectively. At 30 days and 1 year, complications,
patency, and amputation are recorded. Yet, there were some
outstanding issues. Were all procedures on true PA, or were
some performed on pseudoaneurysms? Were they all pri-
mary procedures, or were re-operations also registered?
Were all the pre-operative thrombolysis procedures regis-
tered in the PA module as part of the reconstruction or as
separate interventions for acute ischaemia? To validate the
registry data, and to enable analysis of the details mentioned
above, a questionnaire was created and sent to the 30
hospitals that had treated and registered the patients, and
an additional case record analysis was performed.Retrieval of operations
In the Swedvasc, 668 interventions for PA were registered
between May 2008 and May 2012. Dual registrations such
as pre-operative thrombolysis followed by aneurysm repair
were identiﬁed in Swedvasc and merged. A protocol was
sent out to the 30 institutions having registered the pro-
cedures to verify the remaining registrations (592). The
principal investigator (A.C.) performed 165 of these pro-
tocols in site visits to four larger institutions. The remaining
protocols were registered by co-authors of this paper or by
the local Swedvasc representatives. The following 86 in-
terventions were excluded or merged with other registra-
tions: pre-operative thrombolysis and percutaneous
transluminal angioplasty (29), reoperations (21), in-
terventions on peripheral aneurysms other than PA (26),
and other reasons (10). Ten non-registered interventions on
PA during the designated period were identiﬁed and added
(10/592, 1.7%), seven of which were performed on the
contralateral leg.
When analysing time trends, data were compared with
those during 1994e2002 from a previous publication from
the same database,1e3 except for the incidence of PA repair
when 1994e2001 was used,1 since data from the last 2
months of 2002 were suspected to be incomplete.Statistics
The chi-square test was used for categorical variables. For
continuous variables Levene’s test was used to test normal
distribution. If homogeneity was violated, it was adjusted
for with the BrowneForsythe test. The ANOVA test was
used to compare differences between multiple subgroups,
and the Tukey range test was used for inter-group com-
parisons. All tests were two-tailed. A p value < .01 was
considered signiﬁcant, adjusting for multiple comparisons. A
p value < .05 was considered a statistical trend. Multivar-
iate statistics were not considered feasible because of the
small number of events (occlusion, amputation, death) in
the different subgroups. All statistical analyses were per-
formed using the software package SPSS version 20.0 (IBM
SPSS, Inc.).
Figure 1. Study design.
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Incidence of PA repair
There were 592 interventions for PA (in 499 patients) of
which 587 (99.1%) were cross checked with supplementary
protocols (Fig. 1). All 592 limbs were treated during 4 years
(148/year). Sweden had a population of 9.4 million in 2010,
resulting in an incidence of 15.7 operations/million person
years.Validity of registry based data
To validate the registrations in Swedvasc they were
compared with the Inpatient Registry and it was found that
interventions for PA that were listed in either of the reg-
istries and 91.4% (583/638) were registered in Swedvasc.
Smoking status had missing values in 25%; other pre-
operative risk factors were missing in approximately 7%.
In three of the 484 cases (0.6%) who had undergone open
repair, the exact surgical technique (medial or posterior)
was unknown.Patient characteristics
Of the 592 PAs, 187 (31.6%) were treated emergently and
405 (68.4%) electively. The following four subgroups were
created based on the indication for treatment: rupture 13
(2.2%), acute ischaemia 174 (29.4%), elective symptomatic
105 (17.7%), and asymptomatic 300 (50.7%). In the previous
database,1e3 31.5% were treated for acute ischaemia
(1994e2002, p ¼ .58).
The baseline characteristics of the four groups are
described in Table 1. The p values in Table 1 refer to
comparing all four groups with ANOVA. When comparing
two groups, the group with ruptured PA differs from the
acute ischaemia group in age (p ¼ .006) and frequency of
heart disease (p ¼ .022, trend), from the elective symp-
tomatic in age (p ¼ .023, trend) and from the asymptomatic
in age (p ¼ .013, trend) and frequency of heart disease
(p ¼ .006). The groups acute ischaemia, elective symp-
tomatic and asymptomatic, did not differ signiﬁcantly from
each other in this analysis, nor with an ANOVA test
including these three groups only.Surgical technique
The proportions of surgical techniques used in the four
groups are presented in Fig. 2. There were no differences in
background factors such as heart disease, diabetes, smok-
ing, cerebrovascular disease, hypertension, or age in the
acute ischaemic group when comparing those treated with
ER or OR. In both the elective symptomatic and the
asymptomatic groups, however, those treated with ER were
older than those treated with OR: 78 versus 68 years
(p ¼ .006) and 74 versus 68 years (p < .001) (Table 2). The
proportion of ER increased from 4.7% 1994e2002 (26/558)
to 16.7% 2008e2012 (97/581) (p ¼ .0001) a 3.6 fold
increase.Incompletely treated patients
Eleven patients (1.9%) were treated incompletely: nine with
acute ischaemia (all Rutherford 2b, with neurological
impairment) and two with other symptoms. One underwent
successful thrombolysis but committed suicide before
deﬁnitive treatment. The remaining eight patients with
acute ischaemia had no beneﬁt to the run-off from
thrombolysis, were all amputated within a week, and two
died within 30 days.
Two elective patients underwent incomplete treatment:
one was a 91 year old man with rest pain who underwent
thrombolysis without effect, the other had a distal bypass,
which occluded during the operation; none was amputated.
These 11 patients are not included in Fig. 2, nor in the
description of the medium-term outcome, since different
deﬁnitive treatments are compared.The emergent group
Among the 187 legs that were treated emergently, 13 had a
ruptured aneurysm. This small and special group is not
elaborated on further. The remaining 174 had acute
ischaemia, and they were classiﬁed according to Ruth-
erford8: 23 (13.2%) had Grade 1, 85 (48.9%) Grade 2a, and
63 (36.2%) Grade 2b.The acute ischaemia group
The treatments given to the 174 with acute ischaemia are
summarized in Fig. 3: 118 (67.8%) received pre-operative
thrombolytic treatment, and 92 of those (78.0%) improved
their outﬂow. The duration of thrombolysis was a maximum
of 4 days. Most limbs (87.6%) were treated during 1 or 2
days. In 28 (24%) cases the thrombolysis had to be termi-
nated. The reasons were severe intra cerebral haemorrhage
(1), other bleeding (6), compartment syndrome (6), massive
embolization (1), no effect of thrombolysis (5), and unknown
(9). The time between thrombolysis and operation was
within a week in 79.8% (75/94), median 3 days. Including the
incompletely treated group, the total number of amputa-
tions was 17/170 (10%) at 30 days and 20/159 (13%) at 1
year. Excluding the limbs that were not completely treated
the cumulative amputation rates were 5.6% (9/161) and
8.6% (112/140) at 30 days and 1 year.
Table 1. Background characteristics.
Rupture Acute ischaemia Elective symptomatic Elective asymptomatic ANOVA p All patients
Number 13 174 105 300 499
Median age (range) 79 (63e93) 69 (42e102) 69 (46e93) 69 (50e90) .013 70 (42e102)
Male gender (%) 100 93 95 97 .138 95
Diabetes (%) 0 11 14 16 .288 13
Heart disease (%) 62 26 30 21 .005 27
Respiratory disease (%) 27 11 12 11 .437 12
Hypertension (%) 67 65 62 70 .453 68
RRT (%) 0 0 0 1 1
CVD (%) 25 14 9.3 10 .227 11
Smoker (%)
Never 28 22 26 17 .270 21
Former 43 43 52 57 52
Active 29 35 22 26 27
Note. The clinical subgroups refer to legs, all patients refer to patients, some of them operated on bilaterally, thus sometimes belonging to
two groups. RRT ¼ renal replacement therapy; CVD ¼ cerebrovascular disease; ANOVA ¼ analysis of variance.
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while in the OR group the proportion was 81/137 (60.1%,
p ¼ .083). Outﬂow was improved after thrombolysis in 19/
21 (91%) ER and in 72/84 (86%, p ¼ .566) OR. Another ﬁve
(3.6%) in the OR group had intra-operative thrombolysis.
Primary and secondary patency, amputation, death, and
amputation free survival at 30 days and 1 year among those
operated on with OR and ER are given in Table 3.
In 116 of the bypasses a vein graft was used (89.9%), in
13 a synthetic graft (10.1%), and in nine patients this in-
formation is missing. There was no difference in patency
depending on graft material used (p ¼ .488).
Within 1 year, ﬁve of the patients originally treated with
ER were converted to OR. Three of these were patent 1 year
after re-operation, one was patent after 8 months, and the
information is missing in one.
At 1 year, OR secondary patency with vein grafts was 91%
(87/96) compared with 56% (5/9) among those who had a
synthetic graft (p ¼ .002).Figure 2. Surgical technique.The elective symptomatic group
Of 405 elective operations, 105 were symptomatic, and 103
of those underwent complete treatment of the PA. The
main symptoms were claudication (40/103, 38.8%), rest
pain (29, 28.2%), ischaemic ulcer (22, 21.4%), venous
compression or thrombosis (5, 4.9%), and microembolism
(2, 1.9%). Five cases (4.9%) were considered symptomatic,
but for unknown reasons. Primary and secondary patency,
amputation, death, and amputation free survival at 30 days
and 1 year among the 103 limbs operated on with OR and
ER are given in Table 4.
One aneurysm in the ER group was converted to an open
bypass and remained patent. Two of the stents were
multilayer stents; one occluded after 4 months, was reop-
ened by thrombolysis, and relined with a covered stent
graft. The other remained patent at 1 year.The asymptomatic group
Of the 300 legs with asymptomatic PA, 55 (18.3%) were
treated by ER and 245 (81.7%) by OR. Outcomes among
those operated on by OR and ER are given in Table 5.
In the ER group, one was converted to a bypass within a
month and another two within a year. Two of these were
examined and found to be patent after 1 year. Two legs
were treated with multilayer stents, neither of which was
patent at late follow up.
Of the OR 83.5% (197/236) were reconstructed with vein
bypass, 37 (15.7%) with prosthetic, and two with composite
graft. Vein grafts had a patency of 99.4% at 30 days
compared with 94.7% for prosthetic grafts (p ¼ .017). The
corresponding patency rates at one year were 95.9% versus
80.0% (p ¼ .001).Open repair
Outcomes after OR by graft type are shown in Table 6, and
by surgical approach in Table 7. Vein grafts were used in
87.6% (395/451), and had signiﬁcantly better results both
overall and in the subgroups. A posterior surgical approach
was used in 20.8% (121/581), had better patency at 30 days
Table 2. Background characteristics in context of treatment modality.
Acute ischaemia p Elective symptomatic p Elective asymptomatic p
Surgical technique (n) ER (27) OR (138) ER (13) OR (90) ER (55) OR (245)
Median age, years (range) 70 (46e88) 69 (42e102) .627 78 (63e88) 68 (46e93) .006 74 (53e89) 68 (50e90) <.001
Male gender (%) 85 94 .099 85 97 .059 100 97 .174
Diabetes (%) 20 9.4 .122 8 15 .499 15 16 .884
Heart disease (%) 30 26 .657 46 27 .216 34 18 .012
Respiratory disease (%) 17 10 .303 33 9.4 .018 9.8 11 .742
Hypertension (%) 58 65 .510 64 61 .862 68 70 .725
Cerebral insult (%) 8.3 14 .471 0 9.0 .231 12 10 .621
Smoker (ever) (%) 81 79 .812 63 76 .417 80 84 .525
346 A. Cervin et al.(p ¼ .007), and a trend towards lower amputation risk at 1
year (p ¼ .012). A prosthetic graft was used in 12.0% (36/
337) of medial approach cases and in 18.0% (20/111)
(p ¼ .043) of posterior cases. When a distal bypass was
performed, two of 45 (4.4%) were with a prosthetic graft.DISCUSSION
This observational study was based on prospective report-
ing to the Swedvasc Registry. It gives an opportunity to
study the treatment of this rather rare disease with a
population based design in a contemporary context, and
where time trends can be analysed. One year complete
follow up data were available for 87%, 84%, and 90% among
the survivors in the acute ischaemia, symptomatic, and
asymptomatic groups, respectively, comparing favourably
with previous reports. The main results were an increased
overall surgical activity, a shift towards ER, as well as to-
wards the posterior approach when OR was chosen.
Furthermore, inferior results after ER compared with ORFigure 3. Flow chart of treatment given in the subgroup treated for
acute ischaemia.were found, in particular when the leg was operated on for
acute ischaemia.
In a previous analysis Ravn et al.1 reported an incidence
of PA repair of 8.3 per million person years in 1994e2001 in
Sweden, compared with 15.7 per million person years
during 2008e2012, a doubling of the total surgical activity.
There are great international differences in surgical activity
for PA, and in the recent Vascunet report Sweden had the
highest activity of the eight countries studied.6
The proportion of patients operated on for acute
ischaemia has not changed over time (29.4 vs. 31.5%,
p ¼ .58). Thus, a change in the indications for surgery does
not seem to have taken place. A more reasonable expla-
nation for the increase in surgical activity is either a true
increase in the prevalence of PA or an increased detection
rate. The Swedish abdominal aortic aneurysm (AAA)
screening programme started in Uppsala in 2006, and
reached a more than 99% population coverage in 2014.9,10
Many vascular centres perform a routine ultrasound ex-
amination of the popliteal arteries on patients with newly
detected AAA, but that cannot explain the increase in op-
erations for symptomatic PA. The improved imaging rou-
tines, including duplex ultrasound, computed tomography
angiography and magnetic resonance angiography may
result in a thrombosed PA being detected more frequently
in a patient with acute ischaemia. Finally, there may be is-
sues concerning the structure of the Swedvasc, which was
changed in 20087 permitting a more precise registration of
patients treated for PA. Even before 2008, however, there
was a speciﬁc procedure code for PA repair in the Inpatient
Registry. A previous focused validation of registration of PA
repair in Swedvasc, scrutinizing the case records of patients
with this speciﬁc procedure code showed that in 141 of 146
bilaterally operated patients, 97% had the contralateral
operation registered in Swedvasc, thus showing an excellent
external validity.3
The proportion of ER increased from 4.7%1 to 16.7% in
the present report, a 3.6 fold increase. This seems to be a
global trend, in the previously mentioned Vascunet report
the overall proportion of ER was 22.2%.6 The Vascular
Quality Initiative, a registry including 290 centres in the USA
and Canada, reported an increase of ER from 34.8% in 2010
to 47.6% in 2013.11
This trend could be questioned on the basis the results of
this study.11,12 For the ﬁrst time it has been possible to
Table 3. Outcome after treatment of popliteal aneurysm with acute ischaemia depending on treatment modality.
Total no. 165 Open repair (138) Stent graft (27) p
N/Totala % N/Totala %
Primary patency, 30 days 113/128 88.3 17/27 63.0 0.001
Secondary patency, 30 days 122/131 93.1 19/27 70.4 0.001
Amputation within 30 days 5/134 3.7 4/27 14.8 0.022
Death within 30 days 2/138 1.4 1/27 3.7 0.423
Amputation free survival, 30 days 128/135 94.8 23/27 85.1 0.069
Primary patency, 1 year 89/113 78.8 9/21 42.9 0.001
Secondary patency, 1 year 99/114 86.8 10/21 47.6 <0.001
Amputation within 1 year 8/117 6.8 4/23 17.4b 0.098
Death within 1 year 6/138 4.5 4/27 14.8 0.037
Amputation free survival, 1 year 109/122 89.3 19/25 76.0 0.070
a The total number varies because of some missing data.
b The total number of amputations did not increase between 30 days and 1 year, but two patients died, and two were lost to follow up.
Table 4. Outcome after treatment of symptomatic popliteal aneurysm depending on treatment modality.
Total no. 103 Open repair (90) Stent graft (13) p
N/Totala % N/Totala %
Primary patency, 30 days 83/89 93.2 10/13 77.0 .052
Secondary patency, 30 days 84/89 94.4 12/13 92.3 .767
Amputation within 30 days 3/90 3.3 0/13 0 .504
Death within 30 days 0/90 0 0/13 0 d
Amputation free survival, 30 days 87/90 96.7 13/13 100 .504
Primary patency, 1 year 60/74 81.1 4/7 57.1 .137
Secondary patency, 1 year 64/74 86.5 6/7 85.7 .955
Amputation within 1 year 7/81 8.6 0/9 0 .358
Death within 1 year 5/90 5.6 1/13 7.8 .758
Amputation free survival, 1 year 73/83 88.0 9/9 100 .270
a The total number varies because of some missing data.
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OR for acute ischaemia, as well as for symptomatic and
asymptomatic chronic disease. As can be seen in Table 3,
patency rates at both 30 days and 1 year for those treated
for acute ischaemia are signiﬁcantly worse after ER, and
there is even a trend towards a higher amputation risk. The
secondary patency of ER is almost half that after OR (48%
vs. 87%). Results would have been even worse for ER had
not ﬁve patients been converted to OR between 30 days
and 1 year, since these patients went on to do well without
re-occlusion or amputation. The difference in outcome doesTable 5. Outcome after treatment of asymptomatic popliteal aneurysm
Total no. 300 Open repair (245)
N/Totala
Primary patency, 30 days 232/244
Secondary patency, 30 days 242/245
Amputation within 30 days 0/245
Death within 30 days 0/245
Amputation free survival, 30 days 245/245
Primary patency, 1 year 186/209
Secondary patency, 1 year 200/214
Amputation within 1 year 2/220
Death within 1 year 3/242
Amputation free survival, 1 year 216/221
a The total number varies because of some missing data.
b The total number of amputations did not increase between 30 days anot seem to be explained by case selection; as can be seen
in Table 2 there are no differences in the background
characteristics between those operated on with OR or ER in
the acute ischaemia group. In the symptomatic and
asymptomatic groups those treated with ER were older, but
there are no signiﬁcant differences in the frequency of co-
morbidities.
All the numerical trends disfavour ER including those
presented in Tables 4 and 5 comparing results for patients
treated for symptomatic and asymptomatic disease. The
fact that many of these comparisons do not show signiﬁcantdepending on treatment modality.
Stent graft (55) p
% N/Totala %
95.1 50/53 94.3 .823
98.8 52/55 94.5 .043
0 1/55 1.8 .035
0 0/55 0 d
100 54/55 98.1 .035
89.0 31/46 67.4 <.001
93.5 41/49 83.7 .026
0.9 1/50b 2.0 .507
1.2 3/55 5.4 .045
97.8 48/52 92.3 .048
nd 1 year, but three patients died, and two were lost to follow up.
Table 6. Outcome after open repair depending on graft material.
Indication All procedures p Acute ischaemia p Elective symptomatic p Elective asymptomatic p
Graft material
(N)
Vein 395 Pros. 56 Vein 116 Pros. 13 Vein 82 Pros. 5 Vein 197 Pros. 38
Prim. patency (N)
30 days (%)
363/386
94.0
45/53
84.9
.015 96/108
88.9
9/11
81.8
.488 77/81
95.1
3/5
60.0
.003 190/197
96.4
33/37
89.2
.056
Sec. patency (N)
30 days (%)
378/389
97.2
49/54
90.7
.018 104/111
93.7
10/11
90.9
.722 78/81
96.2
3/5
60.0
.001 196/197
99.4
36/38
94.7
.017
Amputations (N)
30 days (%)
6/391
1.5
2/56
3.6
.282 4/112
3.6
1/13
7.6
.473 2/82
2.4
1/5
20.0
.037 0/197 0/38 e
Prim. patency (N)
1 year (%)
288/331
87.0
32/46
69.6
.002 79/95
83.2
3/9
30.0
<.001 55/67
82.1
2/4
50.0
.117 153/168
91.1
27/33
81.8
.112
Sec. patency (N)
1 year (%)
310/334
92.8
35/48
72.9
<.001 87/96
90.6
5/9
55.5
.002 59/67
88.1
2/4
50.0
.034 164/171
95.9
28/35
80.0
.001
Amputations (N)
1 year (%)
12/347
3.5
5/51
9.8
.036 6/98
6.1
2/10
20
.110 6/73
8.2
1/5
20.0
.373 0/176 2/36
5.6
.002
Pros. ¼ prosthetic graft.
348 A. Cervin et al.differences (p < .01) is likely to be a result of type II sta-
tistical error.
Is it possible that these results after ER, representing
everyday vascular surgery with a mix of academic and
county hospitals, are signiﬁcantly worse than those re-
ported from highly specialized endovascularly oriented
centres? Rather the opposite: these results are similar to
those previously published.5,13e15 Those investigators have
reported high occlusion rates after operation for asymp-
tomatic PA, but better secondary patency, and low ampu-
tation rates. Thus the results are similar to those in Table 5,
which is the relevant comparison, given the fact that
asymptomatic patients dominate in those published series.
Yet, these patients are subjected to the risks associated
with re-interventions,16 veriﬁed in a recent large registry
based survey of the US Medicare population.17 Further-
more, thrombolysis was shown to be at particularly high risk
of complications when performed after a thrombosed PA,18
and the patients will also suffer ischaemic symptoms that
are the result of a thrombosed reconstruction.
Why have these bad results after ER of PA treated for
acute ischaemia not been reported previously? There are
several studies13e15,19,20 looking at stent graft treatment for
PA with short-term results similar to open repair. TheTable 7. Outcome after open repair depending on surgical approach.
Indication All procedures p Acute ischaemia
Surgical approach (N) Medial 349 Post. 121 Medial 112 Post. 2
Prim. patency (N)
30 days (%)
309/340
90.9
118/120
98.3
.007 91/105
86.7
22/23
95.7
Sec. patency (N)
30 days (%)
325/341
95.3
120/121
99.2
.052 97/105
92.4
23/24
95.8
Amputations (N)
30 days (%)
8/345
2.3
0/121
0
.091 5/108
4.6
0/24
0
Prim. patency (N)
1 year (%)
247/296
83.4
89/101
88.1
.261 71/91
78.0
18/22
81.8
Sec. patency (N)
1 year (%)
267/297
89.9
95/104
91.3
.668 79/91
86.8
19/22
86.4
Amputations (N)
1 year (%)
17/308
5.5
0/109
0
.012 8/94
8.5
0/22
0
Post. ¼ posterior approach.numbers of treated legs are quite small however, and most
of the patients are asymptomatic. Furthermore, long-term
results are seldom reported. An exception is a single
centre study from Padova, Italy, on 46 ER (93% elective),
reporting 5 year follow up in 59%.21 Pulli et al.5 reported
the largest experience of ER to date, but of those 134
treated legs only 10 were treated for acute ischaemia, and
the results of those operations were not presented sepa-
rately. Based on the results of this investigation one can
question whether it is ethically acceptable to perform ER of
PA outside trials.
The results of OR are generally speaking excellent. This is
partly a result of the frequent use of vein grafts, the
importance of which has been demonstrated previ-
ously.1,22e24 As can be observed in Table 6, the use of vein
was associated with better patency in all sub-groups, but
again the patients with acute ischaemia beneﬁted most
from this technique. Primary patency in this group was 83%
at 1 year compared with only 30% in those who had a
prosthetic graft, and the secondary patency rates were also
quite different, 91% versus 55%, conﬁrming the great
advantage of vein grafts. A possible explanation for this
clinically important observation is that patients who suffer
acute ischaemia from a PA often have severelyp Elective symptomatic p Elective asymptomatic p
4 Medial 73 Post. 17 Medial 164 Post. 80
.225 66/72
91.7
17/17
100
.218 152/163
93.3
79/80
98.8
.063
0.549 67/72
93.1
17/17
100
.263 161/164
98.2
80/80
100
.224
0.283 3/73
4.1
0/17 .395 0 0 e
0.696 48/60
80.0
12/14
85.7
.623 127/144
88.2
59/65
90.8
.582
0.956 51/60
85.0
13/14
92.9
.439 137/146
93.8
63/68
92.6
.743
0.156 7/65
10.8
0/16
0
.170 2/149
1.3
0/71
0
.327
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thetic grafts and endografts perform badly in this low ﬂow
environment.
No difference was shown in patency between OR with
the medial or posterior approach in any of the subgroups
(Table 7) but adding the groups together there was an
advantage with the posterior approach. The main advantage
of the posterior approach is the decreased risk of late
expansion due to a phenomenon similar to Type II endoleak
after EVAR for AAA.25 This is often a late complication that
develops many years after the primary operation,26 and
could not be expected to affect results within 1 year, which
was the follow up period in this investigation. This point
favouring the posterior approach has been taken up by
many Swedish vascular surgeons, because the use of the
posterior technique increased from 8.6% (60/717) between
1987e20023 to 21.0% (122/581) between 2008 and 2012,
and is used even more often in the elective situation, 26.7%
(80/300). If late expansion after ER happens, it remains an
unresolved problem, but in a recent investigation on 46 ER
with a median follow up of 56 months, no cases of sac
expansion were reported.21
Performing research based on registry data has its
limitations; both external and internal validity can be
questioned. Fortunately, all previous validations of the
Swedvasc Registry have shown excellent general validity,27
as well as speciﬁcally for registration of PA repair.3,28 We
were also able to supplement registry data with a speciﬁc
protocol, which achieved a high response rate (99.1%),
illustrating the dedication of the local Swedvasc repre-
sentatives and the collaborative atmosphere. Some
important data, such as the size and thrombus of the PA,
the anatomy of the run-off vessels, and post-operative
medication are still lacking. The advantage is the large
number of treated limbs, which has made it possible for
the ﬁrst time to perform sub-group analyses when
comparing ER and OR. A follow up study, a case control
study nested in this cohort, is underway in order to
address these outstanding issues. Such a nested case
control study addresses the major weakness of a case
control study, the selection of controls, and is therefore
considered robust by epidemiologists.
This investigation conﬁrms the fact that rupture is an
uncommon event among patients with PA, and the fact that
only 13 patients were treated for rupture makes it difﬁcult to
perform any meaningful analysis. It is obvious from Table 1,
however, that these patients are older than the other groups,
and more than half of them have heart disease.
In conclusion, this contemporary study shows a clinically
important difference in outcome between OR and ER
treatment of PA, favouring OR. Although this ﬁnding may
have been expected, the magnitude of difference in
outcome, in particular among those treated for acute
ischaemia, was unexpected and puts in question the use of
ER for PA outside trials. The use of ER has increased almost
fourfold compared with 1994e2001, illustrating the
importance of this ﬁnding. The advantage of using a vein
graft was conﬁrmed, but since a vein was used in 87.6%,and some patients may not have a suitable vein graft, there
is not much room for improvement in this respect.
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